These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24060470)

  • 1. K-Map: connecting kinases with therapeutics for drug repurposing and development.
    Kim J; Yoo M; Kang J; Tan AC
    Hum Genomics; 2013 Sep; 7(1):20. PubMed ID: 24060470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSigDB: drug signatures database for gene set analysis.
    Yoo M; Shin J; Kim J; Ryall KA; Lee K; Lee S; Jeon M; Kang J; Tan AC
    Bioinformatics; 2015 Sep; 31(18):3069-71. PubMed ID: 25990557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homopharma: a new concept for exploring the molecular binding mechanisms and drug repurposing.
    Chiu YY; Tseng JH; Liu KH; Lin CT; Hsu KC; Yang JM
    BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S8. PubMed ID: 25521038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites.
    Huang HD; Lee TY; Tzeng SW; Horng JT
    Nucleic Acids Res; 2005 Jul; 33(Web Server issue):W226-9. PubMed ID: 15980458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Web-based Tools for Drug Repurposing: Successful Examples of Collaborative Research.
    Vanhaelen Q
    Curr Med Chem; 2021; 28(1):181-195. PubMed ID: 32003659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Web-based drug repurposing tools: a survey.
    Sam E; Athri P
    Brief Bioinform; 2019 Jan; 20(1):299-316. PubMed ID: 29028878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KinasePhos 2.0: a web server for identifying protein kinase-specific phosphorylation sites based on sequences and coupling patterns.
    Wong YH; Lee TY; Liang HK; Huang CM; Wang TY; Yang YH; Chu CH; Huang HD; Ko MT; Hwang JK
    Nucleic Acids Res; 2007 Jul; 35(Web Server issue):W588-94. PubMed ID: 17517770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
    Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
    Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repositioning by integrating target information through a heterogeneous network model.
    Wang W; Yang S; Zhang X; Li J
    Bioinformatics; 2014 Oct; 30(20):2923-30. PubMed ID: 24974205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics.
    Hintzsche JD; Yoo M; Kim J; Amato CM; Robinson WA; Tan AC
    BMC Med Genomics; 2018 Apr; 11(Suppl 2):26. PubMed ID: 29697364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KinView: a visual comparative sequence analysis tool for integrated kinome research.
    McSkimming DI; Dastgheib S; Baffi TR; Byrne DP; Ferries S; Scott ST; Newton AC; Eyers CE; Kochut KJ; Eyers PA; Kannan N
    Mol Biosyst; 2016 Nov; 12(12):3651-3665. PubMed ID: 27731453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of kinase-specific phosphorylation sites through an integrative model of protein context and sequence.
    Patrick R; Horin C; Kobe B; Cao KA; Bodén M
    Biochim Biophys Acta; 2016 Nov; 1864(11):1599-608. PubMed ID: 27507704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
    Islam S; Wang S; Bowden N; Martin J; Head R
    Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugst.One - a plug-and-play solution for online systems medicine and network-based drug repurposing.
    Maier A; Hartung M; Abovsky M; Adamowicz K; Bader GD; Baier S; Blumenthal DB; Chen J; Elkjaer ML; Garcia-Hernandez C; Helmy M; Hoffmann M; Jurisica I; Kotlyar M; Lazareva O; Levi H; List M; Lobentanzer S; Loscalzo J; Malod-Dognin N; Manz Q; Matschinske J; Mee M; Oubounyt M; Pastrello C; Pico AR; Pillich RT; Poschenrieder JM; Pratt D; Pržulj N; Sadegh S; Saez-Rodriguez J; Sarkar S; Shaked G; Shamir R; Trummer N; Turhan U; Wang RS; Zolotareva O; Baumbach J
    Nucleic Acids Res; 2024 Jul; 52(W1):W481-W488. PubMed ID: 38783119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Predikin webserver: improved prediction of protein kinase peptide specificity using structural information.
    Saunders NF; Kobe B
    Nucleic Acids Res; 2008 Jul; 36(Web Server issue):W286-90. PubMed ID: 18477637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of kinase inhibitor response using activity profiling, in vitro screening, and elastic net regression.
    Tran TP; Ong E; Hodges AP; Paternostro G; Piermarocchi C
    BMC Syst Biol; 2014 Jun; 8():74. PubMed ID: 24961498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in designing substrate-competitive protein kinase inhibitors.
    Han KC; Kim SY; Yang EG
    Curr Pharm Des; 2012; 18(20):2875-82. PubMed ID: 22571656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeSigN: connecting gene expression with therapeutics for drug repurposing and development.
    Lee BK; Tiong KH; Chang JK; Liew CS; Abdul Rahman ZA; Tan AC; Khang TF; Cheong SC
    BMC Genomics; 2017 Jan; 18(Suppl 1):934. PubMed ID: 28198666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
    Anastassiadis T; Deacon SW; Devarajan K; Ma H; Peterson JR
    Nat Biotechnol; 2011 Oct; 29(11):1039-45. PubMed ID: 22037377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.